INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.
2024年6月4日，賓夕法尼亞州普利茅斯會議（PRNewswire） - 生物技術公司INOVIO（納斯達克：INO）專注於開發和推廣DNA藥物來幫助治療和預防人類乳頭瘤病毒相關疾病，癌症和傳染病。今天宣佈，INOVIO的總裁兼首席執行官Dr. Jacqueline Shea和首席醫學官Dr. Michael Sumner將參加由Stephens，Inc.的業務部主管和權益研究分析師Sudan Loganathan，博士主持的虛擬爐邊聊天活動。
The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to institutional clients of Stephens. Please reach out to your Stephens contact for event details.
本次爐邊聊天將於2024年6月11日星期二東部時間上午11:00舉行。此活動僅向Stephens的機構客戶開放。請聯繫您的Stephens聯繫人了解活動詳情。
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .
關於INOVIO
INOVIO是一家專注於開發和推廣DNA藥物以幫助治療和預防人類乳頭瘤病毒相關疾病，癌症和傳染病的生物技術公司。 INOVIO的技術優化了設計和交付創新的DNA藥物，教導人體制造自己的抗疾病工具。欲了解更多信息，請訪問。
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Thomas Hong, (267) 440-4298, [email protected]
聯繫方式
媒體：Jennie Willson，（267）429-8567，[email protected]
投資者：Thomas Hong，（267）440-4298，[email protected]
SOURCE INOVIO Pharmaceuticals, Inc.
消息來源：INOVIO Pharmaceuticals，Inc.
譯文內容由第三人軟體翻譯。